FDA Approves Premarket Approval Application for OraQuick HIV Self-Test, Expanding ...
The FDA approved OraQuick In-Home HIV Test for ages 14-17, expanding access for adolescents to test for HIV at home. The test detects HIV-1 and HIV-2 with an oral swab, providing results in 20 minutes, and has 99.98% specificity and 92% sensitivity. This decision aims to reduce barriers to testing and HIV spread.
Highlighted Terms
Related News
FDA Approves Premarket Approval Application for OraQuick HIV Self-Test, Expanding ...
The FDA approved OraQuick In-Home HIV Test for ages 14-17, expanding access for adolescents to test for HIV at home. The test detects HIV-1 and HIV-2 with an oral swab, providing results in 20 minutes, and has 99.98% specificity and 92% sensitivity. This decision aims to reduce barriers to testing and HIV spread.